Prognostic significance of clinical scoring systems for large‐duct primary sclerosing cholangitis in Japanese patients
Journal of Hepato-Biliary-Pancreatic Sciences · 2025
DOI: 10.1002/jhbp.12117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Koji Takahashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Liver Transplantation. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Purpose
This study aimed to identify the significant factors associated with liver transplant‐free survival time in Japanese patients with large‐duct primary sclerosing cholangitis (PSC) by evaluating the association between various parameters and clinical scores at PSC diagnosis.
Methods
This single‐center retrospective study investigated factors influencing liver transplant‐free survival in Japanese large‐duct PSC patients. Univariate analysis using log‐rank tests identified significant clinical parameters and scoring systems, which were further analyzed with multivariate Cox proportional hazards models to determine independent predictors of liver transplant‐free survival.
Results
A total of 77 patients with large‐duct PSC were included. The univariate analysis identified that age ( p < .001), serum albumin level ( p = .024), Child‐Pugh score ( p = .0012), albumin‐bilirubin score ( p = .0083), Amsterdam‐Oxford PSC score ( p < .001), and revised Mayo risk score ( p < .001) were significant predictors of liver transplant‐free survival time. However, the multivariate analysis revealed that only the Amsterdam‐Oxford PSC score remained as an independent factor significantly associated with liver transplant‐free survival time (hazard ratio: 12.90, 95% confidence interval: 2.78–59.81, p = .0011).
Conclusions
This study underscored the importance of utilizing the Amsterdam‐Oxford PSC score in clinical practice to assess disease prognosis and guide patient management in Japanese patients with large‐duct PSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
ORCID-Profile: Koji Takahashi
Zitieren
APA
Takahashi, K., Horio, R., Ohyama, H., Kan, M., Ouchi, M., Nagashima, H., Okitsu, K., Ohno, I., & Kato, N. (2025). Prognostic significance of clinical scoring systems for large‐duct primary sclerosing cholangitis in Japanese patients. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12117
Vancouver
Takahashi K, Horio R, Ohyama H, Kan M, Ouchi M, Nagashima H, et al. Prognostic significance of clinical scoring systems for large‐duct primary sclerosing cholangitis in Japanese patients. Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.12117
BibTeX
@article{Takahashi2025,
author = {Takahashi, Koji and Horio, Ryosuke and Ohyama, Hiroshi and Kan, Motoyasu and Ouchi, Mayu and Nagashima, Hiroki and Okitsu, Kohichiroh and Ohno, Izumi and Kato, Naoya},
title = {Prognostic significance of clinical scoring systems for large‐duct primary sclerosing cholangitis in Japanese patients},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2025},
doi = {10.1002/jhbp.12117}
}
EUVIMED